Instructions for use Title Human Amnion-Derived Mesenchymal Stem Cell Transplantation Ameliorates Liver Fibrosis in Rats

Title Human Amnion-Derived Mesenchymal Stem Cell Transplantation Ameliorates Liver Fibrosis in Rats Author(s) Kubo, Kimitoshi; Ohnishi, Shunsuke; Hosono, Hidetaka; Fukai, Moto; Kameya, Ayano; Higashi, Ryosuke; Yamada, Takahiro; Onishi, Reizo; Yamahara, Kenichi; Takeda, Hiroshi; Sakamoto, Naoya Citation Transplantation Direct, 1(4): e16 Issue Date 2015-05 Doc URL http://hdl.handle.net/2115/62386 Type article

[1]  K. Yamahara,et al.  Human Amnion-Derived Mesenchymal Stem Cell Transplantation Ameliorates Dextran Sulfate Sodium-Induced Severe Colitis in Rats , 2015, Cell transplantation.

[2]  M. Benderitter,et al.  Management of Fibrosis: The Mesenchymal Stromal Cells Breakthrough , 2014, Stem cells international.

[3]  T. Ikeda,et al.  Transplantation of Allogenic Fetal Membrane-Derived Mesenchymal Stem Cells Protects against Ischemia/Reperfusion-Induced Acute Kidney Injury , 2014, Cell transplantation.

[4]  Emmanuel A Tsochatzis,et al.  Liver cirrhosis , 2014, The Lancet.

[5]  Frank Tacke,et al.  Macrophage heterogeneity in liver injury and fibrosis. , 2014, Journal of hepatology.

[6]  Alberto Mantovani,et al.  Macrophage plasticity and polarization in liver homeostasis and pathology , 2014, Hepatology.

[7]  Allison Hubel,et al.  Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices , 2014, Transfusion.

[8]  J. Moraleda,et al.  Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application , 2014, Stem cells and cloning : advances and applications.

[9]  T. Ikeda,et al.  Comparison of Angiogenic, Cytoprotective, and Immunosuppressive Properties of Human Amnion- and Chorion-Derived Mesenchymal Stem Cells , 2014, PloS one.

[10]  R. Malekzadeh,et al.  Randomized placebo‐controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[11]  Y. Moodley,et al.  Anti-Inflammatory Effects of Adult Stem Cells in Sustained Lung Injury: A Comparative Study , 2013, PloS one.

[12]  Ying Sun,et al.  A pilot study of umbilical cord‐derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis , 2013, Journal of gastroenterology and hepatology.

[13]  Shaheen N. Khan,et al.  Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice , 2013, Journal of Translational Medicine.

[14]  B. Wang,et al.  Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. , 2013, Stem Cells and Development.

[15]  O. Ringdén,et al.  Fetal Membrane Cells for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease , 2013, Stem cells.

[16]  S. Friedman,et al.  CD11b+ Gr1+ bone marrow cells ameliorate liver fibrosis by producing interleukin‐10 in mice , 2012, Hepatology.

[17]  T. Ikeda,et al.  Systemic transplantation of allogenic fetal membrane-derived mesenchymal stem cells suppresses Th1 and Th17 T cell responses in experimental autoimmune myocarditis. , 2012, Journal of molecular and cellular cardiology.

[18]  Wei R. Chen,et al.  Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats , 2012, Journal of Translational Medicine.

[19]  J. Iredale,et al.  Macrophages: central regulators of hepatic fibrogenesis and fibrosis resolution. , 2012, Journal of hepatology.

[20]  Shaheen N. Khan,et al.  Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis , 2012, Journal of Translational Medicine.

[21]  Lei Jin,et al.  Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients , 2012, Journal of gastroenterology and hepatology.

[22]  Mohamed Hegazy,et al.  Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells , 2011, European journal of gastroenterology & hepatology.

[23]  L. Peng,et al.  Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short‐term and long‐term outcomes , 2011, Hepatology.

[24]  D. Miao,et al.  Transplanted Human Amniotic Membrane-Derived Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Cirrhosis in Mouse , 2011, PloS one.

[25]  Ping Wang,et al.  Delta-like 1 Serves as a New Target and Contributor to Liver Fibrosis Down-regulated by Mesenchymal Stem Cell Transplantation* , 2011, The Journal of Biological Chemistry.

[26]  W. Xu,et al.  A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalin. , 2011, Die Pharmazie.

[27]  T. Ikeda,et al.  Allogeneic administration of fetal membrane-derived mesenchymal stem cells attenuates acute myocarditis in rats. , 2010, Journal of molecular and cellular cardiology.

[28]  T. Ikeda,et al.  Allogenic fetal membrane-derived mesenchymal stem cells contribute to renal repair in experimental glomerulonephritis. , 2010, American journal of physiology. Renal physiology.

[29]  S. Friedman,et al.  Amelioration of hepatic fibrosis by NK cell activation , 2010, Gut.

[30]  H. Baharvand,et al.  Mesenchymal stem cell infusion therapy in a carbon tetrachloride‐induced liver fibrosis model affects matrix metalloproteinase expression , 2010, Cell biology international.

[31]  C. Esquivel.  Liver transplantation: where we are and where we are heading. , 2010, Transplantation proceedings.

[32]  D. Covas,et al.  Mechanisms involved in the therapeutic properties of mesenchymal stem cells. , 2009, Cytokine & growth factor reviews.

[33]  M. Soleimani,et al.  Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial , 2009, European journal of gastroenterology & hepatology.

[34]  H. Harn,et al.  Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. , 2009, Life sciences.

[35]  F. Tacke,et al.  Monocytes and macrophages as cellular targets in liver fibrosis. , 2009, Inflammation & allergy drug targets.

[36]  S. Hung,et al.  The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[37]  M. Sakaguchi,et al.  Suppression of Carbon Tetrachloride-Induced Liver Fibrosis by Transplantation of a Clonal Mesenchymal Stem Cell Line Derived from Rat Bone Marrow , 2009, Cell transplantation.

[38]  T. Ikeda,et al.  Allogeneic Injection of Fetal Membrane‐Derived Mesenchymal Stem Cells Induces Therapeutic Angiogenesis in a Rat Model of Hind Limb Ischemia , 2008, Stem cells.

[39]  A. Uccelli,et al.  Mesenchymal stem cells in health and disease , 2008, Nature Reviews Immunology.

[40]  R. Malekzadeh,et al.  Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. , 2007, Archives of Iranian medicine.

[41]  D. Sabry,et al.  Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. , 2007, Clinical biochemistry.

[42]  V. Fossati,et al.  Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro , 2007, BMC Developmental Biology.

[43]  H. Ohgushi,et al.  Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. , 2006, Journal of hepatology.

[44]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[45]  P. Xiang,et al.  Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. , 2005, World journal of gastroenterology.

[46]  R. Bataller,et al.  Amendment history : Corrigendum ( April 2005 ) Liver fibrosis Ramón Bataller , 2018 .

[47]  F. Claas,et al.  Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta , 2004, Stem cells.

[48]  H. Nishina,et al.  Transplantation of bone marrow cells reduces CCl4‐induced liver fibrosis in mice , 2004, Hepatology.

[49]  R. Zhao,et al.  Systemic Infusion of FLK1+ Mesenchymal Stem Cells Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis in Mice , 2004, Transplantation.

[50]  R. Zhao,et al.  Isolation and identification of mesenchymal stem cells from human fetal pancreas. , 2003, The Journal of laboratory and clinical medicine.

[51]  R. Willemze,et al.  Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. , 2003, Haematologica.

[52]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[53]  Y. Kaneda,et al.  Hepatocyte growth factor gene therapy of liver cirrhosis in rats , 1999, Nature Medicine.